BALITREO Trademark

Trademark Overview

On Friday, September 9, 2016, a trademark application was filed for BALITREO with the United States Patent and Trademark Office. The USPTO has given the BALITREO trademark a serial number of 79196490. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 12, 2024. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The BALITREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
balitreo

General Information

Serial Number79196490
Word MarkBALITREO
Filing DateFriday, September 9, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 12, 2024
Registration Number5230017
Registration DateTuesday, June 27, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: PUBLISH CUT, And, the standard character claim is inserted.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP

Trademark Events

Event DateEvent Description
Thursday, December 15, 2016ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 6, 2017REFUSAL PROCESSED BY IB
Thursday, November 17, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 18, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, November 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 26, 2016APPLICATION FILING RECEIPT MAILED
Monday, December 19, 2016NON-FINAL ACTION WRITTEN
Wednesday, December 21, 2016REFUSAL PROCESSED BY MPU
Wednesday, December 21, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 27, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 29, 2017FINAL DISPOSITION PROCESSED
Friday, September 29, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 28, 2017ASSIGNED TO LIE
Thursday, March 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 6, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 24, 2019TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 4, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 5, 2019POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, June 12, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, June 21, 2019AMENDMENT UNDER SECTION 7 - PROCESSED
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 27, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 12, 2024CANCELLED SECTION 71
Friday, September 13, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, September 15, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, September 15, 2024INVALIDATION PROCESSED
Monday, October 7, 2024TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

balitreo disease infection disorders system nervous viral pain central neurological musculoskeletal